{
    "clinical_study": {
        "@rank": "112548", 
        "acronym": "CHECKLIST-ICU", 
        "arm_group": [
            {
                "arm_group_label": "Daily checklist and clinician prompting", 
                "arm_group_type": "Experimental", 
                "description": "Usual care, with multidisciplinary daily rounds plus daily checklist and clinical prompting"
            }, 
            {
                "arm_group_label": "Usual care", 
                "arm_group_type": "No Intervention", 
                "description": "Usual care, including multidisciplinary daily rounds."
            }
        ], 
        "brief_summary": {
            "textblock": "CHECKLIST-ICU will be a cluster randomized trial to ascertain whether the use of an\n      intervention including 1) checklists with assessment of daily goals during the\n      multidisciplinary visit, and 2) clinician prompting can reduce in-hospital mortality of\n      patients admitted to intensive care units (ICUs).\n\n      The investigators also aim to describe participant ICUs in terms of the standards for\n      intensive care units proposed by the Brazilian National Health Agency (ANVISA)."
        }, 
        "brief_title": "Checklist During Multidisciplinary Visits for Reduction of Mortality in Intensive Care Units", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Critically Ill Patients", 
        "condition_browse": {
            "mesh_term": "Critical Illness"
        }, 
        "detailed_description": {
            "textblock": "Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization.\n\n      The trial will have two stages:\n\n        -  Stage I - Baseline data.In this stage we will:\n\n             -  Will be applied \"Safety Attitudes Questionnaire\" for the employees of the\n                participating ICU.\n\n             -  Characterize participant ICUs in terms of the standards  (RDC n\u00ba7/2010, RDC\n                n\u00ba26/2012 e RDC n\u00ba 63/2011) for intensive care units proposed by the Brazilian\n                National Health Agency (ANVISA)\n\n             -  Characterize patients: we will collect data from 60 consecutive critically ill\n                patients from each participant ICU to describe adherence to measures aimed at\n                avoiding ICU complications and clinical outcome measures.\n\n        -  Stage II - Intervention: This is the main stage for data analysis. ICUs will be\n           randomly assigned to an experimental or control group. The experimental group should\n           use a multi-item verbal checklist including assessment of daily goals during the\n           multidisciplinary visits plus clinician prompting. We will collect data from 60\n           additional patients for each ICU in both study groups and apply \"Safety Attitudes\n           Questionnaire\"."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria for clusters:\n\n          -  Intensive care units, except dedicated coronary care units/cardiac intensive care\n             units and step-down units;\n\n          -  Must have multidisciplinary daily rounds or coordinators agree to implement daily\n             rounds, including at least one physician and one nurse, conducted at least on week\n             days.\n\n        Exclusion criteria for clusters:\n\n        \u2022 We will exclude ICUs that systematically apply checklists in the multiprofessional daily\n        visit. We define systematically applied checklist when all the following criteria are met:\n\n          -  Content: structured evaluation following a digital or printed document of multiple\n             items focused on prevention of common ICU complications (eg. ventilator-associated\n             pneumonia, stress ulcer, venous thromboembolism and/or catheter-associated\n             bloodstream infection) and/or explicit assessment of daily goals;\n\n          -  Time frame: daily application of checklist for at least 30 days\n\n          -  Periodicity: at least 3 days per week\n\n          -  How is applied: verbal, observational (1 professional check all items), with or\n             without written register\n\n        Patient inclusion criteria:\n\n        \u2022 Adult patients (\u226518 years-old) with anticipated ICU length of stay > 24 hours.\n\n        Patient exclusion criteria;\n\n          -  High probability of death within 24 hours or patients admitted in ICU for palliative\n             care only;\n\n          -  Suspected or confirmed brain death."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785966", 
            "org_study_id": "11673812310010060"
        }, 
        "intervention": {
            "arm_group_label": "Daily checklist and clinician prompting", 
            "description": "Interventions are:\nVerbal multi-item checklist aimed at preventing common critically ill patient complications to be applied in the multidisciplinary daily round.\nClinician prompting: resident physician or nurse prompts intensivists when checklists items were overlooked in the daily round.", 
            "intervention_name": "Daily checklist and clinician prompting", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "critically ill patients", 
            "quality improvement", 
            "checklist"
        ], 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "contact": {
                "email": "knsilva@hcor.com.br", 
                "last_name": "Karina N Silva", 
                "phone": "55xx1130536611", 
                "phone_ext": "8204"
            }, 
            "contact_backup": {
                "email": "abiasi@hcor.com.br", 
                "last_name": "Alexandre B Cavalcanti, MD,PhD", 
                "phone": "55xx1130536611", 
                "phone_ext": "8102"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "04005000"
                }, 
                "name": "Alexandre Biasi Cavalcanti"
            }, 
            "investigator": {
                "last_name": "Alexandre B Cavalcanti, MD.Phd", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Checklist During Multidisciplinary Daily Visits and Clinician Prompting for Reduction of Mortality in Intensive Care Units: A Cluster Randomized Trial", 
        "overall_contact": {
            "email": "knsilva@hcor.com.br", 
            "last_name": "Karina N Silva", 
            "phone": "+55 11 3051-6611", 
            "phone_ext": "8204"
        }, 
        "overall_contact_backup": {
            "email": "abiasi@hcor.com.br", 
            "last_name": "Alexandre B Cavalcanti, MD, PhD", 
            "phone": "+55 11 3051-6611", 
            "phone_ext": "8201"
        }, 
        "overall_official": [
            {
                "affiliation": "Research Institute - Hospital do Coracao", 
                "last_name": "Alexandre B Cavalcanti, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "D'Or Institute for Research and Education", 
                "last_name": "Fernando Bozza, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "D'Or Institute for Research and Education", 
                "last_name": "Jorge I Salluh, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Federal University of Sao Paulo", 
                "last_name": "Fl\u00e1via Machado, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Santo Amaro", 
                "last_name": "Jose M Telles, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital do Coracao", 
                "last_name": "Edson R Romano, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Research Institute - Hospital do Cora\u00e7\u00e3o", 
                "last_name": "Karina N Silva", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Research Institute - Hospital do Coracao", 
                "last_name": "Otavio Berwanger, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Samaritano", 
                "last_name": "Patricia Vendramim, R.N.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Research Institute - Hospital do Coracao", 
                "last_name": "Viviane C Chiattone, RN", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Health Surveillance Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive.", 
            "measure": "In-hospital mortality after 48 hours of ICU admission", 
            "safety_issue": "No", 
            "time_frame": "Hospital discharge; average of 20 days; follow-up limited to 60 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785966"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Head of the bed elevated >=30\u00b0", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "measure": "Oral hygiene with chlorhexidine", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "measure": "Adequate prophylaxis for venous-thromboembolism", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "We will consider patients who do not arouse after voice stimulus as deeply sedated, unless there is contra-indication to keep the patient alert or lightly sedated.", 
                "measure": "Excessive sedation", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive.", 
                "measure": "In-hospital mortality", 
                "safety_issue": "No", 
                "time_frame": "Hospital discharge; average of 20 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Follow-up will be limited to 60 days after ICU admission. Patients who are still in the ICU after 60 days of ICU admission will be considered as discharged alive.", 
                "measure": "Intensive care unit mortality", 
                "safety_issue": "No", 
                "time_frame": "ICU discharge; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2008", 
                "measure": "Catheter-related bloodstream infection", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Ventilator-associated pneumonia as the CDC 2013 definitions for possible or probable ventilator-associated pneumonia", 
                "measure": "Ventilator-associated pneumonia", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "measure": "Mechanical ventilator use rate", 
                "safety_issue": "Yes", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "measure": "Central venous catheter use rate", 
                "safety_issue": "No", 
                "time_frame": "Daily assessment during ICU stay; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Follow-up will be limited to 60 days after ICU admission. Patients who are still in the ICU after 60 days of ICU admission will be considered as discharged alive.", 
                "measure": "Length of ICU stay", 
                "safety_issue": "No", 
                "time_frame": "ICU discharge; average of 10 days; follow-up limited to 60 days"
            }, 
            {
                "description": "Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive.", 
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "Hospital discharge; average of 20 days; follow-up limited to 60 days"
            }, 
            {
                "measure": "Ventilator-free days from day 1 to day 28", 
                "safety_issue": "No", 
                "time_frame": "Day 28 after ICU admission"
            }, 
            {
                "description": "Survey", 
                "measure": "Safety Attitudes Questionnaire Score", 
                "safety_issue": "No", 
                "time_frame": "Will be used at the beginning of the stage one and at the end of the trial"
            }
        ], 
        "source": "Hospital do Coracao", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Hospital Samaritano", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "D'Or Institute for Research and Education", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Hospital do Coracao", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}